Finance

BioMarin Q2 2026 slides: Amicus deal drives 20% revenue growth

https://www.investing.com/news/company-news/biomarin-q2-2026-slides-amicus-deal-drives-20-revenue-growth-93CH-4844749 Investing.com

Major hedge funds targeted in wave of attempted cyberattacks

Bloomberg, Hema Parmar, Katherine Burton, Sridhar Natarajan

Earnings call transcript: electroCore posts Q2 2026 EPS beat, raises outlook

https://www.investing.com/news/transcripts/earnings-call-transcript-electrocore-posts-q2-2026-eps-beat-raises-outlook-93CH-4844729 Investing.com

Major hedge funds targeted in wave of attempted cyberattacks

Bloomberg, Hema Parmar, Katherine Burton, Sridhar Natarajan

Puma Biotech earnings beat by $0.16, revenue topped estimates

https://www.investing.com/news/earnings/puma-biotech-earnings-beat-by-016-revenue-topped-estimates-4844639 Investing.com

Cellectis earnings beat by $0.04, revenue fell short of estimates

https://www.investing.com/news/earnings/cellectis-earnings-beat-by-004-revenue-fell-short-of-estimates-4844640 Investing.com

Latest articles

spot_imgspot_img